bipolar disorder manic depression epidemiology forecast insight

DelveInsight’s ‘Bipolar Disorder (Manic Depression) - Epidemiology Forecast to 2034’ report delivers an in-depth understanding of the disease, historical and forecasted Bipolar Disorder (Manic Depression) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Geography Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2017–2034

Bipolar Disorder (Manic Depression) Understanding

Bipolar Disorder (Manic Depression), previously known as manic depressive illness or manic depression, is a mental disorder characterized by wide mood swings from high (manic) to low (depressed). In manic episodes, a person can be delighted, irritable, and there is a marked increase in activity level, whereas, in depressive episodes, someone might feel sad, indifferent, or hopeless, in combination with a deficient activity level. Hypomanic episodes are also seen in patients, and it is a less severe form of mania. It is divided mainly into four subtypes BD-I, BD-II, cyclothymic disorder, and BD not otherwise specified (BD-NOS); the classification is based on the characteristics of mood swings.

Specifically, the lows that a patient may be feeling, those moments of hopelessness, are the possible symptoms of the depressive moments associated with BD. Bipolar Disorder (Manic Depression) is a lifelong condition that creates unusual mood changes that can vary in length and severity. For people living with Bipolar Disorder (Manic Depression), there are three times as many depressive episodes as manic ones. And those episodes often last 50% longer.

The symptoms of Bipolar Disorder (Manic Depression) include feeling sad or anxious; restless; trouble concentrating or making decisions; trouble falling asleep, waking up too early, or sleeping too much; lack of interest; feeling hopeless or worthless, or thinking about death or suicide; unable to do even simple things, and talking very slowly, feeling like he/she has nothing to say, or forgetting a lot.

Bipolar Disorder (Manic Depression) Diagnosis

There is no test available for the diagnosis, a psychiatrist can diagnose it based on the patient’s history and symptoms. Bipolar Disorder (Manic Depression) is often misdiagnosed as unipolar depression as long as manic episodes do not appear. The diagnosis usually requires a physical examination, psychiatric assessment, mood charting, and the use of ICD-10 or DSM-5 criteria for bipolar episodes in BD. The differential diagnoses are major depression, anxiety disorders, ADHD, personality disorder, drug and alcohol misuse, schizophrenia, in addition to consequences of trauma/brain injury.

Epidemiology Perspective by DelveInsight

The Bipolar Disorder (Manic Depression) epidemiology division provides insights about the historical and current Bipolar Disorder (Manic Depression) patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

• In the 7MM, the total type-specific diagnosed prevalent cases of Bipolar Disorder (Manic Depression) were 1,535,495 for Bipolar I Disorder and 2,016,580 for Bipolar II Disorder in the year 2020.
• In the 7MM, the total severity-specific diagnosed prevalent cases of Bipolar Disorder (Manic Depression) were 137,465, 761,210, and 2,653,401 cases for mild, moderate, and severe, respectively in the year 2020.
• In the 7MM, the total treated cases of Bipolar Disorder (Manic Depression) was 1,887,186 cases in the year 2020, which will probably rise during the study period, i.e., 2017–2034.
• In the year 2020, the total diagnosed prevalent case of Bipolar Disorder (Manic Depression) was 3,552,076 cases in the 7MM which are expected to grow during the study period, i.e., 2017–2034.

The disease epidemiology covered in the report provides historical as well as forecasted Bipolar Disorder (Manic Depression) epidemiology [segmented as Total Diagnosed Prevalent Cases of Bipolar Disorder (Manic Depression), Type-specific Diagnosed Prevalent Cases of Bipolar Disorder (Manic Depression), Severity-specific Diagnosed Prevalent Cases of Bipolar Disorder (Manic Depression), and Total Treated Cases of Bipolar Disorder (Manic Depression)] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017 to 2034.

Country Wise- Bipolar Disorder (Manic Depression) Epidemiology

Estimates show that the highest cases of Bipolar Disorder (Manic Depression) in the 7MM were in the United States, followed by Germany, Italy, the United Kingdom, France, Japan, and Spain in 2020.

• In the United States, the total number of diagnosed prevalent cases of Bipolar Disorder (Manic Depression) was 2,401,287 cases in the year 2020 which are expected to grow during the study period, i.e., 2017–2034.
• In the year 2020, the total diagnosed prevalent cases of Bipolar Disorder (Manic Depression) were 1,004,168 cases in EU-5 which are expected to grow during the study period, i.e., 2017–2034.
• In Japan, the total number of diagnosed prevalent cases of Bipolar Disorder (Manic Depression) was 146,621 cases in the year 2020 which are expected to grow during the study period, i.e., 2017–2034.

Scope of the Report

• The Bipolar Disorder (Manic Depression) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
• The Bipolar Disorder (Manic Depression) Report and Model provide an overview of the risk factors and global trends of Bipolar Disorder (Manic Depression) in the seven major markets (7MM: The United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan).
• The report provides insight about the historical and forecasted patient pool of Bipolar Disorder (Manic Depression) in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Bipolar Disorder (Manic Depression).
• The report provides the segmentation of the Bipolar Disorder (Manic Depression) epidemiology by total diagnosed prevalent cases in the 7MM.
• The report provides the segmentation of the Bipolar Disorder (Manic Depression) epidemiology by type-specific diagnosed prevalent cases in the 7MM.
• The report provides the segmentation of the Bipolar Disorder (Manic Depression) epidemiology by severity-specific diagnosed prevalent cases in the 7MM.
• The report provides the segmentation of the Bipolar Disorder (Manic Depression) epidemiology by total treated cases in the 7MM.

Report Highlights

• 10-year forecast of Bipolar Disorder (Manic Depression) epidemiology
• 7MM Coverage
• Total Diagnosed Prevalent Cases of Bipolar Disorder (Manic Depression)
• Type-Specific Diagnosed Prevalent Cases of Bipolar Disorder (Manic Depression)
• Severity-Specific Diagnosed Prevalent Cases of Bipolar Disorder (Manic Depression)
• Total Treated Cases of Bipolar Disorder (Manic Depression)

KOL-Views

We interview KOL’s and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM concerning the patient population of Bipolar Disorder (Manic Depression)?
• What are the key findings of the Bipolar Disorder (Manic Depression) epidemiology across the 7MM and which country will have the highest number of patients during the study period (2017–2034)?
• What would be the total number of patients of Bipolar Disorder (Manic Depression) across the 7MM during the study period (2017–2034)?
• Among the EU5 countries, which country will have the highest number of patients during the study period (2017–2034)?
• At what CAGR the patient population is expected to grow in the 7MM during the study period (2017–2034)?
• What are the various recent and upcoming events which are expected to improve the diagnosis of Bipolar Disorder (Manic Depression)?

Reasons to buy

The Bipolar Disorder (Manic Depression) Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Bipolar Disorder (Manic Depression) market
• Quantify patient populations in the global Bipolar Disorder (Manic Depression) market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the gender that presents the best opportunities for Bipolar Disorder (Manic Depression) therapeutics in each of the markets covered
• Understand the magnitude of the Bipolar Disorder (Manic Depression) population by its severity
• The Bipolar Disorder (Manic Depression) epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists
• The Bipolar Disorder (Manic Depression) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population